Mark J. Vignola
CIK 1775429 · Chief Financial Officer · last filed 2025-01-06
Mark J. Vignola is a Chief Financial Officer who has filed 11 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing shows the insider sold $99.0K of TERN on Jan 6, 2025. Across all open-market trades the lifetime net is −$159.6K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
11
-$159.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Terns Pharmaceuticals, Inc. (TERN) Delisted | Chief Financial Officer | 83,811 | $52.95 | $4.44M | -$159.6K | 10 | 2025-01-06 |
| Applied Therapeutics, Inc. (APLT) Delisted | Chief Financial Officer | — | $0.10 | — | $0 | 1 | 2019-05-15 |
Recent Filings
11 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-01-06 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Sell (S) | −17,188 | -$99.0K | EDGAR |
| 2024-09-12 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Mixed | — | -$56.4K | EDGAR |
| 2024-06-04 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Buy (P) | +4,791 | $21.3K | EDGAR |
| 2024-01-25 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Grant (A) | +68,750 | $0 | EDGAR |
| 2023-12-04 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Buy (P) | +743 | $2.8K | EDGAR |
| 2023-06-02 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Buy (P) | +9,997 | $14.1K | EDGAR |
| 2023-02-03 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Mixed | +3 | $4 | EDGAR |
| 2022-06-08 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Buy (P) | +7,656 | $11.3K | EDGAR |
| 2022-01-28 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-09-30 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Grant (A) | — | $0 | EDGAR |